The former president of South Africa Jacob Zuma is facing some corruption allegations. However, he did not attend his corruption trial, due to his illness. His doctors said he was not fit to attend the trial.
Apparently, it is reported that the former president Jacob Zuma is allegedly over a medical parole , which is two months before ConCourt contempt sentence ends.
However, it seems as if there is a battle over Jacob Zuma's medical parole. The legal team of the former president Jacob Zuma and the department of correctional services have been ordered to prove that Jacob Zuma qualify for the medical parole, which will continue in the SCA in August. They have been given until June to file papers with the Supreme court of appeal.
It's a battle over Jacob Zuma's medical parole? What do you think? Comment below.
Thank you for reading, and do not forget to like, share and follow for more articles. Leave your comment below the comment section.
Content created and supplied by: Amarie (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More